BidaskClub downgraded shares of Surgery Partners (NASDAQ:SGRY) from a hold rating to a sell rating in a report issued on Saturday morning, BidAskClub reports.

Several other equities analysts also recently commented on SGRY. Benchmark upgraded Surgery Partners from a hold rating to a buy rating and set a $14.00 target price for the company in a research report on Monday, April 27th. ValuEngine lowered Surgery Partners from a strong-buy rating to a buy rating in a research note on Thursday, April 2nd. Royal Bank of Canada restated a buy rating and issued a $14.00 target price on shares of Surgery Partners in a research note on Wednesday, May 13th. Finally, Citigroup upped their target price on shares of Surgery Partners from $10.00 to $15.00 and gave the stock a buy rating in a report on Wednesday, May 13th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $15.60.

NASDAQ:SGRY opened at $10.47 on Friday. The company has a debt-to-equity ratio of 2.84, a quick ratio of 1.37 and a current ratio of 1.49. The company has a 50-day moving average of $12.52 and a 200-day moving average of $12.97. Surgery Partners has a 52 week low of $4.00 and a 52 week high of $19.74. The company has a market capitalization of $528.93 million, a price-to-earnings ratio of -4.31 and a beta of 3.45.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.62) by $0.28. The firm had revenue of $441.00 million during the quarter, compared to analyst estimates of $377.50 million. Surgery Partners had a negative net margin of 4.38% and a negative return on equity of 2.21%. Sell-side analysts forecast that Surgery Partners will post -1.34 EPS for the current year.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Bank of Montreal Can boosted its stake in Surgery Partners by 32.4% in the fourth quarter. Bank of Montreal Can now owns 3,865 shares of the company’s stock worth $61,000 after purchasing an additional 946 shares in the last quarter. Two Sigma Advisers LP acquired a new stake in shares of Surgery Partners in the first quarter valued at $76,000. Royal Bank of Canada raised its holdings in shares of Surgery Partners by 199.9% in the first quarter. Royal Bank of Canada now owns 16,156 shares of the company’s stock valued at $106,000 after buying an additional 10,769 shares during the last quarter. Citigroup Inc. lifted its position in Surgery Partners by 247.4% during the 1st quarter. Citigroup Inc. now owns 18,713 shares of the company’s stock worth $122,000 after buying an additional 13,327 shares in the last quarter. Finally, Deutsche Bank AG lifted its position in Surgery Partners by 164.8% during the 1st quarter. Deutsche Bank AG now owns 21,326 shares of the company’s stock worth $139,000 after buying an additional 13,273 shares in the last quarter. Hedge funds and other institutional investors own 93.05% of the company’s stock.

Surgery Partners Company Profile

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Recommended Story: Quiet Period Expirations

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.